Business & Industry
AstraZeneca Secures Global Rights for Zegfrovy Lung Cancer Therapy
AstraZeneca has expanded its oncology pipeline through a $1.5 billion agreement with Dizal Pharma, securing the Zegfrovy global rights. This oral lung cancer therapy, also known as sunvozertinib, is an irreversible EGFR inhibitor. Currently, sunvozertinib is approved in China...
Business & Industry
FDA Proposes New Rule for Drug Manufacturing Registration
The modernization of regulatory frameworks is becoming essential to support the pharmaceutical industry’s transition toward advanced production models and to ensure the resilience of global supply chains. As innovative manufacturing technologies emerge, traditional oversight mechanisms must evolve to maintain...
News
How Modern Wellness Research Is Shaping Health Innovation
Science has always driven progress in health, but the pace of that progress has changed dramatically in recent years. Researchers are now looking beyond traditional medicine and exploring how the body's own biological systems can inform better approaches to...
News
The Starting Material Dilemma: De-Risking Early-Stage CAR-T and Immuno-Oncology Pipelines
The Operational Bottleneck in Advanced Therapeutics
The cell and gene therapy sector has transitioned from a proof of concept frontier into a highly competitive commercial market. While advanced gene editing tools like CRISPR and novel viral vectors dominate industry headlines,...
Industry Reports
Study Identifies Tiered Manufacturing in Global Pharmaceutical Markets
A new research project from the Johns Hopkins Bloomberg School of Public Health has identified a pharmaceutical industry practice that could be a significant factor in global health disparities. Published in PLOS Global Public Health on July 07, 2026,...
News
Enclomiphene Dosage and What to Expect in the First 90 Days
You have decided to try enclomiphene. Now what?
For many men, the first 90 days are the most important period of treatment. This is when the body begins responding, lab markers start to change, and the provider can see whether...
News
Digital Twins in Pharmaceutical Manufacturing: Why Simulation Alone Is No Longer Enough
Pharmaceutical manufacturers have gotten very good at producing data. Production systems log environmental data, equipment performance, quality data, and batch outputs in real-time. However, a lot of manufacturing decisions are still made after a deviation has already taken place,...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
Must read